NO972558L - Sett for osteoporose-behandlingssyklus - Google Patents

Sett for osteoporose-behandlingssyklus

Info

Publication number
NO972558L
NO972558L NO972558A NO972558A NO972558L NO 972558 L NO972558 L NO 972558L NO 972558 A NO972558 A NO 972558A NO 972558 A NO972558 A NO 972558A NO 972558 L NO972558 L NO 972558L
Authority
NO
Norway
Prior art keywords
treatment cycle
osteoporosis treatment
osteoporosis
solvate
kit
Prior art date
Application number
NO972558A
Other languages
English (en)
Other versions
NO972558D0 (no
Inventor
Martine Gazard
Olivier Gros
Jacques Girard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO972558D0 publication Critical patent/NO972558D0/no
Publication of NO972558L publication Critical patent/NO972558L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives et sett for anvendelse i en terapeutisk syklus basert på sekvensiell tilførsel av tiludronsyre eller av et salt og/eller solvat av denne, og av kalsium i 28 til 31 dager, for behandling og/eller forebygging av osteoporose.
NO972558A 1994-12-06 1997-06-05 Sett for osteoporose-behandlingssyklus NO972558L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9414630A FR2727629A1 (fr) 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose
PCT/FR1995/001596 WO1996017616A1 (fr) 1994-12-06 1995-12-05 Trousse pour cycle de traitement de l'osteoporose

Publications (2)

Publication Number Publication Date
NO972558D0 NO972558D0 (no) 1997-06-05
NO972558L true NO972558L (no) 1997-08-05

Family

ID=9469504

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972558A NO972558L (no) 1994-12-06 1997-06-05 Sett for osteoporose-behandlingssyklus

Country Status (20)

Country Link
EP (1) EP0797444A1 (no)
JP (1) JPH10509729A (no)
KR (1) KR980700083A (no)
CN (1) CN1168634A (no)
AR (1) AR002946A1 (no)
AU (1) AU4307396A (no)
BR (1) BR9509961A (no)
CA (1) CA2207028A1 (no)
CZ (1) CZ175397A3 (no)
FI (1) FI972383A0 (no)
FR (1) FR2727629A1 (no)
HU (1) HUT77382A (no)
IL (1) IL116168A0 (no)
MA (1) MA23737A1 (no)
NO (1) NO972558L (no)
PL (1) PL320564A1 (no)
SK (1) SK68597A3 (no)
TR (1) TR199501530A1 (no)
WO (1) WO1996017616A1 (no)
ZA (1) ZA9510184B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
ES2532393T3 (es) 2002-05-10 2015-03-26 F. Hoffmann-La Roche Ag Acidos bisfosfónicos para tratamiento y prevención de osteoporosis
DE60315514T3 (de) * 2002-12-20 2012-04-26 F. Hoffmann-La Roche Ag Hochdosierte ibandronat-formulierung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583887D1 (de) * 1984-04-30 1991-10-02 Procter & Gamble Ausruestung fuer die behandlung der osteoporose.
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DE69316013T2 (de) * 1992-06-30 1998-07-09 Procter & Gamble Pharma Verwendung von phosphinate zur behandlung der osteoporose
FR2694558B1 (fr) * 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
CZ175397A3 (en) 1997-10-15
NO972558D0 (no) 1997-06-05
BR9509961A (pt) 1997-11-25
JPH10509729A (ja) 1998-09-22
PL320564A1 (en) 1997-10-13
FR2727629B1 (no) 1997-02-28
AR002946A1 (es) 1998-05-27
HUT77382A (hu) 1998-04-28
CA2207028A1 (en) 1996-06-13
IL116168A0 (en) 1996-01-31
SK68597A3 (en) 1997-11-05
MX9704105A (es) 1997-09-30
AU4307396A (en) 1996-06-26
ZA9510184B (en) 1996-06-11
EP0797444A1 (fr) 1997-10-01
MA23737A1 (fr) 1996-07-01
CN1168634A (zh) 1997-12-24
TR199501530A1 (tr) 1996-10-21
KR980700083A (ko) 1998-03-30
WO1996017616A1 (fr) 1996-06-13
FI972383A (fi) 1997-06-05
FI972383A0 (fi) 1997-06-05
FR2727629A1 (fr) 1996-06-07

Similar Documents

Publication Publication Date Title
DE122006000010I2 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in derBehandlung von kardiovaskularen Krankheiten
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DE69721766D1 (de) Neue arzneiformulierung
DE3463442D1 (en) Arched bridge staple
NO307408B1 (no) Aminosukker og glykosaminglykansammensetning for behandling og reparasjon av bindevev
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
DK0480934T3 (da) Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt
PT705100E (pt) Guanidinas substituidas terapeuticas
DK549189A (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
TW360544B (en) Analgestic and antiinflammatory fomentation pharmaceutical composition
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
NO305581B1 (no) Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose
ATE203907T1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
ATE131060T1 (de) Chenodeoxycholsäure oder ursodeoxycholsäure zur behandlung von erkrankungen der atmungsorgane.
NO972558L (no) Sett for osteoporose-behandlingssyklus
NO155375C (no) Naturlig vev egnet for implantering i en levende kropp samt fremgangsmaate til aa redusere forkalkningen av naturlig vev som finner sted etter implanteringen i en levende kropp
NZ326345A (en) Composition containing diosgenin
DK325289A (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
DE69218200T2 (de) Behandlung von leberkrebs
DK0583281T3 (da) Modgift - immunsera
SE8501202D0 (sv) Human intestinal hormone and its use
NO960347L (no) Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF
KR960700729A (ko) 26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders)